Interstitial irradiation as a salvage technique
Forty patients with recurrent pelvic malignancies were irradiated using temporary /sup 192/Ir and/or permanent /sup 125/I implants. All patients had a previous course of pelvic irradiation to doses of 5,000 to 6,000 rad over five to eight weeks; patients with cervical and vaginal carcinomas had intracavitary irradiation as well (3,000 to 5,000 mg-hrs). Overall local control was achieved in 27 of 40 patients (67.5%); 13 of these patients remain alive to a minimum follow-up period of 2 years. Eighty percent of the patients experienced good paliation of pain, bleeding, lymphadema of legs, etc. Overall complicatin rate has been 20%, with three patients having developed enterovaginal and vesicovaginal fistulae. (JMT)
- Research Organization:
- LAC/USC Medical Center, Los Angeles, CA
- OSTI ID:
- 5572490
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 7:11
- Country of Publication:
- United States
- Language:
- English
Similar Records
Treatment of bulky stage IB and IIB cervical cancers with outpatient neutron brachytherapy, external pelvic radiation and extrafascial hysterectomy
Physics Contributions and Clinical Outcome With 3D-MRI-Based Pulsed-Dose-Rate Intracavitary Brachytherapy in Cervical Cancer Patients
Related Subjects
FEMALE GENITALS
NEOPLASMS
RADIOTHERAPY
IODINE 125
IRIDIUM 192
PATIENTS
RADIATION DOSES
RADIATION SOURCE IMPLANTS
SIDE EFFECTS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
DAYS LIVING RADIOISOTOPES
DISEASES
DOSES
ELECTRON CAPTURE RADIOISOTOPES
HEAVY NUCLEI
IMPLANTS
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IODINE ISOTOPES
IRIDIUM ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
MEDICINE
MINUTES LIVING RADIOISOTOPES
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ODD-ODD NUCLEI
ORGANS
RADIATION SOURCES
RADIOISOTOPES
RADIOLOGY
THERAPY
YEARS LIVING RADIOISOTOPES
550604* - Medicine- Unsealed Radionuclides in Therapy- (1980-)